bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Pangolin homology associated with 2019-nCoV

2

Tao Zhang1*, Qunfu Wu1*, Zhigang Zhang1#

3

1

4

School of Life Sciences, Yunnan University, Kunming, Yunnan, 650091, China

5

*

These authors contributed equally

6

#

Correspondence to: zhangzhigang@ynu.edu.cn (Z.Z.G.)

State key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan,

1

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Abstract

2

To explore potential intermediate host of a novel coronavirus is vital to rapidly control

3

continuous COVID-19 spread. We found genomic and evolutionary evidences of the

4

occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan

5

Pangolins. Pangolin-CoV is 91.02% and 90.55% identical at the whole genome level to

6

2019-nCoV and BatCoV RaTG13, respectively. Pangolin-CoV is the lowest common

7

ancestor of 2019-nCoV and RaTG13. The S1 protein of Pangolin-CoV is much more

8

closely related to 2019-nCoV than RaTG13. Five key amino-acid residues involved in the

9

interaction with human ACE2 are completely consistent between Pangolin-CoV and 2019-

10

nCoV but four amino-acid mutations occur in RaTG13. It indicates Pangolin-CoV has

11

similar pathogenic potential to 2019-nCoV, and would be helpful to trace the origin and

12

probable intermediate host of 2019-nCoV.

2

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

In the late December of 2019, an epidemic pneumonia (the W.H.O. announced it

2

recently as Corona Virus Disease (COVID-19)(1)) outbreak in city of Wuhan in China and

3

soon widely spreads all over the world. According to authoritative statistics, the COVID-

4

19 has caused more than 40,000 laboratory-confirmed infections with more than 1000

5

deaths by 12 February 2020 and is still increasing. It was caused by a novel identified

6

coronavirus 2019-nCoV (the International Committee on Taxonomy of Viruses (ICTV)

7

renamed this virus as severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (1)).

8

Released complete genomes of 2019-nCoVs (2, 3) have helped rapid identification and

9

diagnosis of the COVID-19. Another key task is to find potential origin of 2019-nCoV(4).

10

Unsurprisingly, like SARS-CoV and MERS-CoV(5), the bat is still a probable origin of the

11

2019-nCoV because the 2019-nCoV shared 96% whole genome identity with a bat

12

coronavirus Bat-CoV-RaTG13 from Rhinolophus affinis from Yunnan Province(2).

13

However, SARS-CoV and MERS-CoV usually pass into medium host like civets or camels

14

before leaping to humans(4). It indicates that the 2019n-Cov was probably transmitted to

15

humans by some other animals. Considering the earliest COVID-19 patient reported no

16

exposure at the seafood market(6), finding intermediate host of 2019-nCoV is vital to block

17

its transmission.

18

On 24 October 2019, Liu and his colleagues from the Guangdong Wildlife Rescue

19

Center of China (7) ﬁrstly detected the existence of SARS-liked coronavirus from lung

20

samples of two dead Malayan Pangolins with a frothy liquid in lung and pulmonary ﬁbrosis,

3

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

which is close on the outbreak of COVID-19. From their published results, all virus contigs

2

assembled from 2 lung samples (lung07, lung08) showed not high identities ranging from

3

80.24% to 88.93% with known SARS coronavirus. Hence, we conjectured that dead

4

Malayan pangolin may carry a new coronavirus close to 2019-nCoV.

5

To confirm our assumption, we downloaded raw RNA-seq data (SRA accession

6

number PRJNA573298) of those two lung samples from SRA and conducted consistent

7

quality control and contamination removing as described by Liu’s study(7). We found 1882

8

clean reads from lung08 sample mapped upon 2019-nCoV reference genome (GenBank

9

Accession MN908947)(3) with high genome coverage of 76.02%. We performed de novo

10

assembly of those reads and totally obtained 36 contigs with length ranging from 287bp to

11

2187bp with mean length of 700bp. Blasting against proteins from 2845 coronavirus

12

reference genomes including RaTG13, 2019-nCoVs and other known coronaviruses, we

13

found 22 contigs can be best matched to 2019-nCoVs (70.6%-100% aa identity; average:

14

95.41%) and 12 contigs matched to Bat SARS-like coronavirus (92.7%-100% aa identity;

15

average: 97.48%) (Table S1). These results indicate Malayan pangolin indeed carries a

16

novel coronavirus (here named as Pangolin-CoV) close to 2019-nCoV.

17

Using reference-guided scaffolding approach, we created Pangolin-CoV draft

18

genome (19,587 bp) based on the above 34 contigs. Remapping 1882 reads against the draft

19

genome resulted in 99.99% genome coverage at a mean depth of 7.71 X (range: 1X-47X)

20

(Figure 1A). Based on Simplot analysis, Pangolin-Cov showed highly overall genome

4

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

sequence identity throughout the genomes to RaTG13 (90.55%) and 2019-nCoV (91.02%)

2

(Figure 1B), although there is greatly high identity 96.2% between 2019-nCoV and

3

RaTG13(3). Another SARS-like coronavirus more similar to Pangolin-Cov were Bat

4

SARSr-CoV ZXC21(85.65%) and Bat SARSr-CoV ZC45 (85.01%). These results indicate

5

Pangolin-Cov may be the common origin of 2019-nCoV and RaTG13.

6

The viral genome organization of Pangolin-Cov was characterized by sequence

7

alignment against 2019-nCoV (GenBank Accession MN908947) and RaTG13. The

8

Pangolin-Cov genome consists of six major open reading frames (ORFs) common to

9

coronaviruses and other four accessory genes (Figure 1C and Table S2). Further analysis

10

indicates that Pangolin-Cov genes covered 2019-nCoV genes with coverage ranging from

11

45.8% to 100% (average coverage 76.9%). Pangolin-Cov genes shared high average

12

nucleotide and amino identity with both 2019-nCoV (MN908947) (93.2% nt/ 94.1% aa)

13

and RaTG13 (92.8% nt/93.5% aa) (Figure 1C and Table S2). Surprisingly, some of

14

Pangolin-Cov genes showed higher aa sequence identity to 2019-nCoV than RaTG13,

15

including orf1b (73.4/72.8), S-protein (97.5/95.4), orf7a (96.9/93.6), and orf10 (97.3/94.6).

16

High S-protein amino acid identity implies function similarity between Pangolin-Cov and

17

2019-nCoV.

18

To determine the evolutionary relationships among Pangolin-Cov, 2019-nCoV and

19

previously identified coronaviruses, we estimated phylogenetic trees based on the

20

nucleotide sequences of the whole genome sequence, RNA-dependent RNA polymerase

5

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

gene (RdRp), non-structural protein genes ORF1a and 1b, and the main structural proteins

2

encoded by the S and M genes. In all phylogenies, Pangolin-CoV, RaTG13 and 2019-nCoV

3

were clustered into a well-supported group, here named as “SARS-CoV-2 group” (Figure

4

2 and Figures S1 to S2). This group represents a novel Beta-coronaviruses group. Within

5

this group, RaTG13 and 2019-nCoV was grouped together, and the Pangolin-CoV was

6

their lowest common ancestor. However, whether the basal position of the SARS-CoV-2

7

group is SARSr-CoV ZXC21 and/or SARSr-CoV ZC45 or not is still in debate. Such

8

debate also occurred in both Wu et al.(3) and Zhou et al. (2)studies. Possible explanation

9

is due to a past history of recombination in Beta-CoV group(3). It is noteworthy that our

10

discovered evolutionary relationships of coronaviruses shown by the whole genome, RdRp

11

gene, and S-gene were highly consistent with that discovered by complete genome

12

information in Zhou et al. study(2). It indicates our Pangolin-CoV draft genome has enough

13

genomic information to trace true evolutionary position of Pangolin-CoV in coronaviruses.

14

The coronavirus spike (S) protein consisting of 2 subunits (S1 and S2) mediates

15

infection of receptor-expressing host cells and is a critical target for antiviral neutralizing

16

antibodies. S1 contains a receptor binding domain (RBD) about 193 amino acid fragment,

17

which is responsible for recognizing and binding with the cell surface receptor(8, 9). Zhou

18

et al. had experimentally confirmed that 2019-nCoV is able to use human, Chinese

19

horseshoe bats, civet, and pig ACE2 as an entry receptor in the ACE2-expressing cells(2),

20

suggesting the RBD of 2019-nCoV mediates infection to human and other animals. To gain

6

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

a sequence-level insight into understanding pathogen potential of Pangolin-Cov, we

2

investigated the amino acid variation pattern of S1 protein from Pangolin-CoV, 2019-

3

nCoV, RaTG13, and other representative SARS-CoVs. The amino acid phylogenetic tree

4

showed the S1 protein of Pangolin-CoV is more closely related to that of 2019-CoV than

5

RaTG13. Within the RBD, we further found Pangolin-CoV and 2019-nCOV was highly

6

conserved with only one amino acid change (500H/500Q) (Figure 3) but not belonging to

7

five key residues involved in the interaction with human ACE2(2, 9). In contrast, RaTG13

8

has 17 amino acid residue changes and 4 of them belonged to key amino acid residue

9

(Figure 3). These results indicate Pangolin-Cov has similar pathogen potential to 2019-

10

nCoV.

11

The nucleocapsid protein (N-protein) is the most abundant protein in coronavirus.

12

The N-protein is a highly immunogenic phosphoprotein, and it is normally very conserved.

13

The N protein of coronavirus is often used as a marker in diagnostic assays. To gain a

14

further insight into the diagnostic potential for Pangolin-Cov, we investigated the amino

15

acid variation pattern of N-protein from Pangolin-CoV, 2019-nCoV, RaTG13, and other

16

representative SARS-CoV. Phylogenetic analysis based on N protein supports Pangolin-

17

Cov as a sister taxon of 2019-nCoV and RaTG13 (Figure 4). We further found seven amino

18

acid mutations can differentiate our defined “SAR-CoV-2 group” (12N, 26 G, 27S, 104D,

19

218A, 335T, 346N, 350Q) from other known SARS-CoVs (12S, 26D, 27N, 104E, 218T,

20

335H, 346Q, 350N). Two amino acid sites (38P and 268Q) are shared by Pangolin-Cov,

7

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

RaTG13 and SARS-CoVs, which are mutated as 38S and 268A in 2019-nCoV. Only one

2

amino acid residue shared by Pangolin-CoV and other SARS-CoVs (129E) is consistently

3

changed in both 2019-nCoV and RaTG13 (129D). Our observed amino acid changes in N-

4

protein would be useful for developing antigen for much more sensitive serological

5

detection of 2019-nCoV.

6

Based on published metagenomic data, this study provides the first report on a

7

potential closely related kin (Pangolin-CoV) of 2019-nCoV, which was discovered from

8

dead Malayan Pangolins after extensive rescue efforts. Aside from RaTG13, the Pangolin-

9

CoV is the most closely related to 2019-nCoV. Due to original sample unavailable, we did

10

not perform further experiments to confirm our findings, including PCR validation,

11

serological detection, and even the isolation of virus particle etc. However, on 7 February,

12

researchers from the South China Agricultural University in Guangzhou reported pangolin

13

would be the potential candidate host of 2019-nCoV for isolating a virus 99% similar to

14

2019-nCoV in genome (Data unpublished). Our discovered Pangolin-CoV genome showed

15

91.02% nt identity with 2019-nCoV, implying Pangolin-CoV could be different from that

16

unpublished. Whether pangolin species is a good candidate for 2019-nCoV still need to be

17

further investigated. Considering the wide spread of SARSr-CoV in their natural reservoirs,

18

our findings would be meaningful to find novel intermediate hosts of 2019-nCoV for

19

blocking interspecies transmission.

8

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Materials and Methods

2

Data preparation

3

We downloaded raw data of lung08 and lung07 published by Liu’s study(7) from

4

NCBI sequence read archive (SRA) under Bio Project PRJNA573298. Raw reads were

5

first adaptor- and quality-trimmed using the Trimmomatic program (version 0.39)(10). For

6

removing host contamination, Bowtie2 (version 2.3.4.3) (11)was used to map clean reads

7

to the host reference genome of Manis javanica (NCBI Project ID: PRJNA256023). Only

8

unmapped reads were mapped to 2019-nCoV reference genome (GenBank Accession

9

MN908947) for identifying virus reads.

10

Read Assembly and construction of consensus sequence

11

Virus-targeted reads were assembled de novo using MEGAHIT (v1.1.3)(12). Read

12

remapping to assembled contigs was performed by using Bowtie2(11). Mapping coverage

13

and depth were produced using Samtools (version 1.9)(13). Contigs were taxonomically

14

annotated using BLAST 2.9.0+ against 2845 Coronavirus reference genomes (Table S1).

15

Bat-Cov-RaTG13 genome was downloaded from NGDC database (https://bigd.big.ac.cn/)

16

(Accession no. GWHABKP00000000)(2). 2019-nCoV reference genome was downloaded

17

from NCBI (Accession no. MN908947)(3). Other coronavirus genomes were downloaded

18

ViPR database (https://www.viprbrc.org/brc/home.spg?decorator=corona) on 6 February

19

2020. We further used reference-guided strategy to construct draft genome based on those

20

contigs taxonomically annotated to 2019-nCoVs, SARS-CoV, and Bat SARS-like CoV.

9

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Each contig was aligned against 2019-nCoV reference genome with MUSCLE software

2

(version 3.8.31)(14). Aligned contigs were merged into consensus scaffold with BioEdit

3

version

4

alignment-editor.html) following manually quality checking. Small fragments with less

5

than length 25bp were discarded, if these fragments were not covered by any large

6

fragments. The potential open reading frames (ORFs) of finally obtained draft genome

7

were annotated by the alignment to 2019-nCoV reference genome (Accession no.

8

MN908947).

9

Phylogenetic relationship analysis

7.2.5

(http://www.mybiosoftware.com/bioedit-7-0-9-biological-sequence-

10

Sequence alignment was carried out using MUSCLE software(14). Alignment

11

accuracy was checked manually base-by-base. Gblocks(15) was used to process the gap in

12

aligned sequence. Using MegaX (version 10.1.7)(16), we inferred all maximum likelihood

13

(ML) phylogenetic trees under the best-fit DNA/anima acid substitute model with 1000

14

bootstrap replications. Phylogenetic analyses were performed using the nucleotide

15

sequences of various CoV gene data sets: the whole genome and ORF1a, ORF1b,

16

Membrane (M) gene, spike (S) and RNA-dependent RNA polymerase (RdRp) gene. The

17

best model of M is GTR+G and all others are GTR+G+I. Two additional protein-based

18

trees were constructed under WAG+G (S1 subunit of S protein) and JTT+G (N-protein),

19

respectively. Branches with values< 70% bootstrap were hidden in all phylogenetic trees.

20

Acknowledgments:

10

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

This

study

was

supported

2

Second Tibetan Plateau Scientific Expedition and Research (STEP) program (no.

3

2019QZKK0503), the National Key Research and Development Program of China (no.

4

2018YFC2000500), the Key Research Program of the Chinese Academy of Sciences (no.

5

KFZD-SW-219), and the Chinese National Natural Science Foundation (no. 31970571).

11

by

the

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Figure legends

2

Figure 1. Genome-related analysis. (A) Sequence depth of mapped reads remapping to

3

Pangolin-Cov. (B) Similarity plot based on the full-length genome sequence of Pangolin-

4

Cov. Full-length genome sequences of 2019-nCoV (Beta-CoV/Wuhan-Hu-1), BatCov-

5

RaTG13, Bat SARSr-CoV 21, Bat SARSr-CoV45, Bat SARSr-CoV WIV1, and SARS-

6

CoV BJ01 were used as reference sequences. (C) Comparison of common genome

7

organization similarity among 2019-nCoV, Pangolin-Cov and BatCov-RaTG13 linked to

8

Table S2.

9

Figure 2. Phylogenetic relationship of coronavirus based on whole genome and RdRp gene

10

nucleotide sequences. Red text denotes the Malayan Pangolin-CoV. Pink text denotes

11

2019-nCoV (SARS-CoV-2). Green text denotes a bat coronavirus having 96% similarity

12

at genome level to SARS-CoV-2. Blue text denotes reference coronaviruses used in

13

Figure1B. Detailed information can be found in Materials and Methods.

14

Figure 3. Amino acid sequence alignment of the S1 protein and its phylogeny. The

15

receptor-binding motif of SARS-CoV and the homologous region of other coronaviruses

16

are indicated by the grey box. The key amino acid residues involved in the interaction with

17

human ACE2 are marked with the orange box. Bat SARS-like CoVs had been reported not

18

to use ACE2, had amino acid deletions at two motifs marked by the yellow box. Detailed

19

information can be found in Materials and Methods.

12

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

Figure 4. Amino acid sequence alignment of N protein and its phylogeny. Highly-

2

conserved amino acid residues in N-protein marked by colors have diagnostic potential.

3

Detailed information can be found in Materials and Methods.

13

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1

References

2

1.

A. E. Gorbalenya, Severe acute respiratory syndrome-related coronavirus – The

3

species and its viruses, a statement of the Coronavirus Study Group. bioRxiv,

4

2020.2002.2007.937862 (2020).

5

2.

bat origin. Nature, https://doi.org/10.1038/s41586-020-2008-3 (2020).

6
7

3.

4.

5.

6.

7.

8.

20

X.-Y. Ge et al., Isolation and characterization of a bat SARS-like coronavirus that uses
the ACE2 receptor. Nature 503, 535-538 (2013).

18
19

P. Liu, W. Chen, J.-P. Chen, Viral metagenomics revealed sendai virus and coronavirus
infection of Malayan Pangolins (Manis javanica). Viruses 11, 979 (2019).

16
17

C. Huang et al., Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. Lancet 395, 497-506 (2020).

14
15

W. Li et al., Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676679 (2005).

12
13

J. Cui, F. Li, Z.-L. Shi, Origin and evolution of pathogenic coronaviruses. Nat. Rev.
Microbiol. 17, 181-192 (2019).

10
11

F. Wu et al., A new coronavirus associated with human respiratory disease in China.
Nature, https://doi.org/10.1038/s41586-020-2012-7 (2020).

8
9

P. Zhou et al., A pneumonia outbreak associated with a new coronavirus of probable

9.

S. K. Wong, W. Li, M. J. Moore, H. Choe, M. Farzan, A 193-amino acid fragment of
the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J.

14

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

Biol. Chem. 279, 3197-3201 (2004).

1
2

10.

sequence data. Bioinformatics 30, 2114-2120 (2014).

3
4

11.

B. Langmead, S. L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat. Meth.
9, 357-359 (2012).

5
6

A. M. Bolger, M. Lohse, B. Usadel, Trimmomatic: a flexible trimmer for Illumina

12.

D. Li, C.-M. Liu, R. Luo, K. Sadakane, T.-W. Lam, MEGAHIT: an ultra-fast single-

7

node solution for large and complex metagenomics assembly via succinct de Bruijn

8

graph. Bioinformatics 31, 1674-1676 (2015).

9

13.

2078-2079 (2009).

10
11

14.

R. C. Edgar, MUSCLE: multiple sequence alignment with high accuracy and high
throughput. Nucleic Acids Res. 32, 1792-1797 (2004).

12
13

H. Li et al., The sequence alignment/map format and SAMtools. Bioinformatics 25,

15.

G. Talavera, J. Castresana, Improvement of phylogenies after removing divergent

14

and ambiguously aligned blocks from protein sequence alignments. Syst. Biol. 56,

15

564-577 (2007).

16
17

16.

S. Kumar, G. Stecher, M. Li, C. Knyaz, K. Tamura, MEGA X: molecular evolutionary
genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547-1549 (2018).

15

Figure 1
A

30
20
10
0

Sequensing depth

40

Genome Coverage: 99.99% (19585nt/19587nt)
Mean depth: 7.71

0

5000

10000

15000

20000

Genome nucleotide position
B 100
Percentage nucleotide identity

90
80
70
60

Query: Pangolin CoV

50

Beta-CoV/Wuhan-Hu-1 (91.02%)
Bat CoV RaTG13 (90.55%)
Bat SARSr-CoV ZXC21(85.65%)
Bat SARSr-CoV ZC45 (85.01%)
Bat SARSr-CoV WIV1(73.94%)
SARS-CoV BJ01 (73.62)

40

0

5000

10000

15000

20000

25000

30000

Genome nucleotide position
C

1a

2019-nCoV

Human

1a
89.9/96.8

Pangolin Pangolin CoV

1a
90.3/97.0

Bat

1b

1b
S

3a

E

M

6

E 67a
10
3a M 8 N

S
7a

8

N

Mean
10 (DNA/AA %)

90.7/73.4 88.3/97.5 94.5/96.8 98.3/97.4 93.0/98.6 95.1/96.3 92.0/96.9 91.7/94.8 94.9/96.4 99.1/97.3 93.2/94.1

1b

S

3a

E

M

6

7a

8

N

10

Mean
(DNA/AA %)

19,587 bp

90.4/72.8 87.3/95.4 95.0/96.8 98.3/97.4 93.0/98.6 93.8/96.3 90.4/93.6 91.5/96.6 95.4/96.4 98.3/94.6 92.8/93.5

Bat CoV RaTG13
0

29,903 bp

29,855 bp
10000

20000

30000

Figure 1. Genome-related analysis. (A) Sequence depth of mapped reads remapping to Pangolin-Cov. (B)
Similarity plot based on the full-length genome sequence of Pangolin-Cov. Full-length genome sequences of
2019-nCoV (Beta-CoV/Wuhan-Hu-1), BatCov-RaTG13, Bat SARSr-CoV 21, Bat SARSr-CoV45,
Bat SARSr-CoV WIV1, and SARS-CoV BJ01 were used as reference sequences. (C) Comparison of common
genome organization similarity among 2019-nCoV, Pangolin-Cov and BatCov-RaTG13 l inked to Table S2.

100 SARS-CoV SZ3
100 SARS-CoV BJ01

RdRp

Bat SARSr-CoV YNLF31C

Bat SARSr-CoV WIV1
100
100 Bat SARSr-CoV SHC014
81 SARS-CoV SZ3
100 SARS-CoV BJ01
100
Bat SARSr-CoV YNLF31C
100
Bat SARSr-CoV GX2013
100 Bat SARSr-CoV Rp3
99
Bat SARSr-CoV SC2018

100

100

Bat SARSr-CoV Rf1
100 Bat SARSr-CoV SX2013

100

Bat SARSr-CoV HuB2013
Bat SARSr-CoV ZXC21

Bat SARSr-CoV Longquan-140

100
100

Bat SARSr-CoV ZC45

Bat SARSr-CoV ZXC21
Pangolin-CoV
Bat CoV RaTG13
Beta-CoV/Wuhan/IPBCAMS-WH-03

100
100

100

Beta-CoV/Wuhan-Hu-1

100

100

100 Beta-CoV/Wuhan/IPBCAMS-WH-03
Beta-CoV/Wuhan/IPBCAMS-WH-04

Beta-CoV/Wuhan/IPBCAMS-WH-05

Beta-CoV/Wuhan/IPBCAMS-WH-05

Bat SARSr-CoV BM48-31

Bat Hp-BetaCoV Zhejiang2013

Bat Hp-BetaCoV Zhejiang2013

MERS-CoV

Rousettus bat CoV HKU9
MERS-CoV

Tylonycteris bat CoV HKU4

100

Pipistrellus bat CoV HKU5

Tylonycteris bat CoV HKU4
100

100
100
100

Rousettus bat CoV HKU9

Pipistrellus bat CoV HKU5
Human CoV HKU1

Human CoV HKU1

Mus musculus MHV-1

100

Human CoV OC43
100

TGEV

100
100

Human CoV NL63
Human CoV 229E

100

100

PEDV
Scotophilus bat CoV 512

100

Miniopterus bat CoV HKU8
100

Miniopterus bat CoV1

Alpha-CoV

Rhinolophus bat CoV HKU2

99

100

0.20

Mus musculus MHV-1
100

Human CoV OC43

TGEV
Mink-CoV

Mink-CoV

0.50

Beta-CoV/Wuhan-Hu-1

92 Beta-CoV/Wuhan/IPBCAMS-WH-01
Beta-CoV/Wuhan/IPBCAMS-WH-02

Beta-CoV/Wuhan/IPBCAMS-WH-01

100

Bat SARSr-CoV Longquan-140

Bat CoV RaTG13

100 Beta-CoV/Wuhan/IPBCAMS-WH-04

100

Bat SARSr-CoV HKU3-1

Bat SARSr-CoV BM48-31
Pangolin-CoV

SARS-CoV-2
group

Beta-CoV/Wuhan/IPBCAMS-WH-02

100

100 Bat SARSr-CoV Rf1
Bat SARSr-CoV SX2013

Bat SARSr-CoV HKU3-1

100

100

Bat SARSr-CoV SC2018

85

Bat SARSr-CoV ZC45

100

Bat SARSr-CoV GX2013

Bat SARSr-CoV HuB2013

100

SARS-CoV-2
group

100 Bat SARSr-CoV WIV16
Bat SARSr-CoV Rs4231

Beta-CoV

100

Bat SARSr-CoV WIV1
100 Bat SARSr-CoV SHC014
81
Bat SARSr-CoV Rp3

PEDV
Scotophilus bat CoV 512

98

Rhinolophus bat CoV HKU2
100

Miniopterus bat CoV HKU8
Miniopterus bat CoV1
Human CoV NL63

93

Human CoV 229E

Figure 2. Phylogenetic relationship of coronavirus based on whole genome and RdRp gene nucleotide sequences. Red text
denotes the Malayan Pangolin-CoV. Pink text denotes 2019-nCoV (SARS-CoV-2). Green text denotes a bat coronavirus having 96%
similarity at genome level to SARS-CoV-2. Blue text denotes reference coronaviruses used in Figure1B. Detailed information can be
found in Materials and Methods.

Beta-CoV

100 Bat SARSr-CoV WIV16
100 Bat SARSr-CoV Rs4231

Alpha-CoV

Figure 2
Whole Genome

Figure 3

340

350

360

370

380

390

400

410

420

430

. . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . .

PN
Beta-CoV/Wuhan-Hu-1
Beta-CoV/Wuhan/IPBCAMS-WH-02 . .
Beta-CoV/Wuhan/IPBCAMS-WH-05 . .
Beta-CoV/Wuhan/IPBCAMS-WH-03 . .
Beta-CoV/Wuhan/IPBCAMS-WH-04 . .
Beta-CoV/Wuhan/IPBCAMS-WH-01 . .
. .
Pangolin-CoV
. .
Bat_CoV_RaTG13
. .
SARS-CoV_SZ3
. .
SARS-CoV_BJ01
. .
Bat_SARSr-CoV_WIV1
. .
Bat_SARSr-CoV_WIV16
. .
Bat_SARSr-CoV_ZXC21
. .
Bat_SARSr-CoV_ZC45
. .
Bat_SARSr-CoV_YNLF31C
. .
Bat_SARSr-CoV_SX2013
. .
Bat_SARSr-CoV_Rf1
. .
Bat_SARSr-CoV_Rp3
. .
Bat_SARSr-CoV_GX2013
. .
Bat_SARSr-CoV_HKU3-1
. .
Bat_SARSr-CoV_Longquan-140
. .
Bat_SARSr-CoV_SC2018
. .
Bat_SARSr-CoV_HuB2013

I
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

T N L C P F G E V F N A T R F A S V Y AWN R K R
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . .T. . . . . . . . . . .
. . . . . . . . . . . . .T. . . . . . . . . . .
. . . . . . . . . . . . .K.P. . . . .E. . .
. . . . . . . . . . . . .K.P. . . . .E. .K
. . . . . . . . . . . . .T.P. . . . .E. . .
. . . . . . . . . . . . .T.P. . . . .E. . .
. . V . . . HK . . . . . . . P . . . . . E . T K
. . V . . . HK . . . . . . . P . . . . . E . T K
. . . . . . DK . . . . . . . P . . . . . E . T K
. . . . . . DK . . . . . . . P . . . . . E . T K
. . . . . . DK . . . . . . . P . . . . . E . T K
. . R . . . DK . . . . . . . PN . . . . E . T K
. . R . . . DK . . . . . . . PN . . . . E . T K
. . R . . . DK . . . . . . . PN . . . . E . T K
. . R . . . DK . . . V . . . PN . . . . E . T K
. . R . . . DK . . . . S . . P . . . . . E . I K
. . R . . . DR . . . . S . . P . . . . . E . T K

440

450

I
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

460

S NCV ADY S V L Y NS AS F S T F KCY GV S P T KL NDL CF T NV Y ADS F V I RGDE V RQ I AP GQT GK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . .T. . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. . . . . . . . . . . . . .R
. . . . . . . . . . . . .T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T. . . . . . . . . . . . . .
. . . . . . . . . . . . . T . . . . . . . . . . . A . . . . . . . . S . . . . . . . . VK . . D . . . . . . . . . . V
. . . . . . . . . . . . . TF . . . . . . . . . . A . . . . . . . . S . . . . . . . . VK . . D . . . . . . . . . . V
. . . . . . . . . . . . . T . . . . . . . . . . . A . . . . . . . . S . . . . . . . . VK . . D . . . . . . . . . . V
. . . . . . . . . . . . . T . . . . . . . . . . . A . . . . . . . . S . . . . . . . . VK . . D . . . . . . . . . . V
.D. I . . .T .F . . .T . . . . . . . . . . . .S . . I . . . . .S . . . .T .L . .FS . . . .V . . . . . .V
.D. I . . .T .F . . .T . . . . . . . . . . . .S . . I . . . . .S . . . .T .L . .FS . . . .V . . . . . .V
.D. . . . .T .F . . .T . . . . .N. . . . . .S . . I . . . . .S . . . .T .L . .FS . . . .V . . . . . .V
.D. . . . .T .F . . .T . . . . .N. . . . . .S . . I . . . . .S . . . .T .L . .FS . . . .V . . . . . .V
.D. . . . .T .F . . .T . . . . .N. . . . . .S . . I . . . . .S . . . .T .L . .FS . . . .V . . . . . .V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V
. D . . . . . T . . . . . T . . . . . . . . . . . . S . . I . . . . . S . . . . T . L . . SS . . . . V . . . E . . V

470

480

490

500

510

I
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

ADYNYKL PDDF
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
.G. . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .

432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432
432

520

. . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . .

T G C V I A W N S N N L D S K V G G N Y N Y L Y R L F R K S N L K P F E R D I S T E I Y Q A G T P C N G V E G F N C Y F P L Q S Y G F Q P T N G V G Y Q P Y R V V V L S F E L L H A 522
Beta-CoV/Wuhan-Hu-1
Beta-CoV/Wuhan/IPBCAMS-WH-02 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522
Beta-CoV/Wuhan/IPBCAMS-WH-05 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522
Beta-CoV/Wuhan/IPBCAMS-WH-03 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522
Beta-CoV/Wuhan/IPBCAMS-WH-04 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522
Beta-CoV/Wuhan/IPBCAMS-WH-01 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H . . . . . . . . . . . . . . . . . . . . N . 522
Pangolin-CoV
. . . . . . . . . K H I . A . E . . . F . . . . . . . . . A . . . . . . . . . . . . . . . . . K . . . . Q T . L . . . Y . . Y R . . . Y . . D . . . H . . . . . . . . . . . . . N . 522
Bat_CoV_RaTG13
M . . . L . . . T R . I . A T S T . . . . . K . . Y L . H G K . R . . . . . . . N V P F S P D K . . T P - P - L . . . W . . K D . . . Y T . S . I . . . . . . . . . . . . . . . N . 520
SARS-CoV_SZ3
M
. . . L . . . T R . I . A T S T . . . . . K . . Y L . H G K . R . . . . . . . N V P F S P D K . . T P - P - L . . . W . . N D . . . Y T . T . I . . . . . . . . . . . . . . . N . 520
SARS-CoV_BJ01
. . . . L . . . T R . I . A T Q T . . . . . K . . S L . H G K . R . . . . . . . N V P F S P D K . . T P - P - . . . . W . . N D . . . Y I . . . I . . . . . . . . . . . . . . . N . 520
Bat_SARSr-CoV_WIV1
.
. . . L . . . T R . I . A T Q T . . . . . K . . S L . H G K . R . . . . . . . N V P F S P D K . . T P - P - . . . . W . . N D . . . Y I . . . I . . . . . . . . . . . . . . . N . 520
Bat_SARSr-CoV_WIV16
. . . . . . . . T A K Q . T G H - - - - - . F . . S H . S T K . . . . . . . L . S . - - - - - - - - - - - - - - . G V R T . S - . D . N . N V P L E . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_ZXC21
.
. . . . . . . T A K Q . V G N - - - - - . F . . S H . S T K . . . . . . . L . S . - - - - - - - - - - - - - - . G V R T . S - . D . N . N V P L E . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_ZC45
. . . . . . . . T A K Y . V G S - - - - - . F . . S H . S . K . . . . . . . L . S . - - - - - - - - - - - - - - . G A R T . S - . D . N Q N V P L E . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_YNLF31C
.
. . . . . . . T A K Q . V G S - - - - - . F . . S H . S . K . . . . . . . L . S . - - - - - - - - - - - - - - . G V R T . S - . D . N Q Y V P L E . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_SX2013
. . . . . . . . T A K Q . V G S - - - - - . F . . S H . S . K . . . . . . . L . S . - - - - - - - - - - - - - - . G V R T . S - . D . N Q N V P L E . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_Rf1
.
. . . . . . . T A K Q . Q G Q - - - - - . Y . . S H . . T K . . . . . . . L . S . - - - - - - - - - - - - - - . G V R T . S - . D . Y . S V P . A . . A T . . . . . . . . . . N . 502
Bat_SARSr-CoV_Rp3
. . . . . . . . T A K Q . T G N - - - - - . Y . . S H . . T K . . . . . . . L . S D - - - - - - - - - - - - - - . G V Y T . S T . D . N . N V P . A . . A T . . . . . . . . . . N . 503
Bat_SARSr-CoV_GX2013
.
. . . . . . . T A K H . T G N - - - - - . Y . . S H . . T K . . . . . . . L . S D - - - - - - - - - - - - - - . G V Y T . S T . D . N . N V P . A . . A T . . . . . . . . . . N . 503
Bat_SARSr-CoV_HKU3-1
. . . . . . . . T A K Q . I G N - - - - - . Y . . S H . . T K . . . . . . . L . S D - - - - - - - - - - - - - - . G V Y T . S T . D . N . N V P . A . . A T . . . . . . . . . . N . 503
Bat_SARSr-CoV_Longquan-140
. . . . . . . . T A K Q . T G S - - - - - . Y . . S H . . T K . . . . . . . L . S D - - - - - - - - - - - - - - . G V Y T . S T . D . N . N V P . A . . A T . . . . . . . . . . N . 503
Bat_SARSr-CoV_SC2018
. . . . . . . . T A K Q . T G Y - - - - - . Y . . S H . . T K . . . . . . . L . S D - - - - - - - - - - - - - - . G V Y T . S T . D . N . N V P . A . . A T . . . . . . . . . . N . 503
Bat_SARSr-CoV_HuB2013

99
93
93
99
99
91
72
96
98
100

84

Figure 3. Amino acid sequence alignment of the S1 protein and its phylogeny.
The receptor-binding motif of SARS-CoV and the homologous region of other
coronaviruses are indicated by the grey box. The key amino acid residues involved
in the interaction with human ACE2 are marked with the orange box. Bat SARS-like
CoVs had been reported not to use ACE2, had amino acid deletions at two motifs
marked by the yellow box. Detailed information can be found in Materials and Methods.

Figure 4

10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
.... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... |

Beta-CoV/Wuhan-Hu-1
MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAAL
Beta-CoV/Wuhan/IPBCAMS-WH-02 .......-....................................................................................................................................................................................................................
Beta-CoV/Wuhan/IPBCAMS-WH-03 .......-....................................................................................................................................................................................................................
Beta-CoV/Wuhan/IPBCAMS-WH-05 .......-....................................................................................................................................................................................................................
Beta-CoV/Wuhan/IPBCAMS-WH-01 .......-....................................................................................................................................................................................................................
Beta-CoV/Wuhan/IPBCAMS-WH-04 .......-....................................................................................................................................................................................................................
.......-.............................P.................................................................................................................................................................................S....
Bat_CoV_RaTG13
.......-................A............P...........................R..............................................................E......N.............................................................T......................
Pangolin-CoV
.......-..SS............SDNS.....N...P.........................N.T..............K......................E........................E........................................................................................T..
Bat_SARSr-CoV_ZXC21
.......-...S............SDNSK....N...P.........................N.T..............K......................E........................E........................................................................................T..
Bat_SARSr-CoV_ZC45
.......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..
SARS-CoV_SZ3
.......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..
SARS-CoV_BJ01
.......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..
Bat_SARSr-CoV_WIV1
.......P...S.........T.P.DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..
Bat_SARSr-CoV_SHC014
.......P...S.........T..IDN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..
Bat_SARSr-CoV_WIV16
......H-...S.S.......T...DN....G.N...P.........................E.R..Q..........G..............V........E................S.......E.......................N....T..................................GN................I.SG..ET..
Bat_SARSr-CoV_YNLF31C
.......P...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E.......................N....T..................................GN...........N......SG..ET..
Bat_SARSr-CoV_Rs4231
.......-S..S.........T..ADN..D.G.....P.........................E.R.............GK........K....V........E................S.......E..V....................N.......................................GN...........N....L.SG..ET..
Bat_SARSr-CoV_Longquan-140
.......-S..S.........A..NDN..D.G.....P.........................E.R.............GK.............V........E................S.......E..V....................N.............................S.........GN...........S....L.SG..ET..
Bat_SARSr-CoV_HKU3-1
.......S...S..S......T...DN..D.G.....P.........................E.R.............GK.............V........E................S.......E..V...I................N.......................................GN...........N....L.SG..ET..
Bat_SARSr-CoV_GX2013
Bat_SARSr-CoV_Rf1
.......-..CS.............DN..D.G.....P.........................G....Q..........GR.............V........E................S.......E..V....................N.........................N.............GN..T........N....V.SG..ET..
Bat_SARSr-CoV_SX2013
.......-...S.............DN..D.G...V.P.........................G....Q..........GR.............V........E................S.......E..V....................N.........................N.............GN..T........N....V.SG..ET..
.......-...S.............DN..D.G.....P.........................E.R.............GK.............V........E................S.......E..V....................N.......................................GN...........N......SG..ET..
Bat_SARSr-CoV_HuB2013
.......-...S.........T...DN..D.G.....P.........................E.R.............GK.............V........E................S.......E..V....................N.......................................GN...........N......SG..ET..
Bat_SARSr-CoV_Rp3
.......-...S.........T...DN..D.G.....P.........................E...............GK.............V........E................S.......E..V....................N.......................................GN...........N......SG..ET..
Bat_SARSr-CoV_SC2018
230
240
250
260
270
280
290
300
310
320
330
340
350
360
370
380
390
400
410
420
.... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | .... | ...

ALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMS--SADSTQA*
Beta-CoV/Wuhan-Hu-1
Beta-CoV/Wuhan/IPBCAMS-WH-02 .................................................................................................................................................................................................--.......*
Beta-CoV/Wuhan/IPBCAMS-WH-03 .................................................................................................................................................................................................--.......*
Beta-CoV/Wuhan/IPBCAMS-WH-05 .................................................................................................................................................................................................--.......*
Beta-CoV/Wuhan/IPBCAMS-WH-01 .................................................................................................................................................................................................--.......*
Beta-CoV/Wuhan/IPBCAMS-WH-04 .................................................................................................................................................................................................--.......*
.......................S.......................Q.................................................................................................................................................--.......*
Bat_CoV_RaTG13
...............................................Q................................Q.................................................................------------------------------..-N.............--.......*
Pangolin-CoV
............N.I................................Q..................................................................H..........Q...N.............................L......................E..........G--T.....*
Bat_SARSr-CoV_ZXC21
............N.V................................Q..................................................................H..........Q...N.............................L......................E..........G--T.....*
Bat_SARSr-CoV_ZC45
..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
SARS-CoV_SZ3
..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
SARS-CoV_BJ01
..............V.....................R..........Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_WIV1
..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_SHC014
..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_WIV16
Bat_SARSr-CoV_YNLF31C
..............V................................Q............D.........D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_Rs4231
..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
..............V.......P........................Q..................................................................H..........Q...N..........................T..A.P....P...P.........M....R...N...GA.......*
Bat_SARSr-CoV_Longquan-140
..............V.......P........................Q............................I.....................................H..........Q...N..........................T..A.P........P.........M....R...H...GA.......*
Bat_SARSr-CoV_HKU3-1
..............V................................Q......................D.T.........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_GX2013
..............V................TS..............Q............D........................................S..........I.H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_Rf1
..............V.................S..............Q............D.....................................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_SX2013
..............V................................S..................................................................H..........Q...N..........................T..A.P....-...P.........M....R...N...GA.......*
Bat_SARSr-CoV_HuB2013
..............V..RS............................Q..................................................................H..........Q...N............I.............T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_Rp3
..............V................................Q..................................................................H..........Q...N.M..........A.............T..A.P........P.........M....R...N...GA.......*
Bat_SARSr-CoV_SC2018

93
96
100
100
100

65
90
100

52

Figure 4. Amino acid sequence alignment of N protein and its phylogeny. Highly-conserved amino acid residues in N-protein marked by
colors have diagnostic potential. Detailed information can be found in Materials and Methods.

100 Bat SARSr-CoV Rs4231

M

99

Bat SARSr-CoV SHC014
73 Bat SARSr-CoV WIV16

Bat SARSr-CoV WIV1
100
100 Bat SARSr-CoV SHC014

Bat SARSr-CoV YNLF31C
89 Bat SARSr-CoV Rf1
100 Bat SARSr-CoV SX2013

81 SARS-CoV SZ3
100 SARS-CoV BJ01
100
Bat SARSr-CoV YNLF31C

SARS-CoV SZ3
70
99 SARS-CoV BJ01

100
Bat SARSr-CoV GX2013
100 Bat SARSr-CoV Rp3
99
Bat SARSr-CoV SC2018

Bat SARSr-CoV SC2018
91 Bat SARSr-CoV Rs4231
Bat SARSr-CoV GX2013

Bat SARSr-CoV HuB2013
100

Bat SARSr-CoV Rp3
64
77
55 Bat SARSr-CoV Longquan-140
67 Bat SARSr-CoV HuB2013
100 Bat SARSr-CoV HKU3-1

Bat SARSr-CoV Rf1
100 Bat SARSr-CoV SX2013
Bat SARSr-CoV Longquan-140

100 Bat SARSr-CoV ZXC21
Bat SARSr-CoV ZC45

SARS-CoV-2
group

Pangolin-CoV

100
100

Bat CoV RaTG13

100

Beta-CoV

Bat SARSr-CoV HKU3-1

100100

SARS-CoV-2
group

100 Bat SARSr-CoV ZXC21
51 Bat SARSr-CoV ZC45
Pangolin-CoV

Bat CoV RaTG13

Beta-CoV/Wuhan-Hu-1

68 Beta-CoV/Wuhan/IPBCAMS-WH-01
Beta-CoV/Wuhan/IPBCAMS-WH-02
99 Beta-CoV/Wuhan/IPBCAMS-WH-03

100 Beta-CoV/Wuhan/IPBCAMS-WH-04
Beta-CoV/Wuhan/IPBCAMS-WH-01

95

Beta-CoV/Wuhan/IPBCAMS-WH-05
Bat SARSr-CoV BM48-31

Beta-CoV/Wuhan/IPBCAMS-WH-04
Beta-CoV/Wuhan/IPBCAMS-WH-05

69

Bat Hp-BetaCoV Zhejiang2013

100

Bat Hp-BetaCoV Zhejiang2013
Rousettus bat CoV HKU9

Rousettus bat CoV HKU9
MERS-CoV

MERS-CoV
100

Tylonycteris bat CoV HKU4
100

100
100
100

Pipistrellus bat CoV HKU5
Human CoV HKU1
Mus musculus MHV-1

100

TGEV

99

Mink-CoV

100

Human CoV 229E

100

100

PEDV
Scotophilus bat CoV 512

100

Miniopterus bat CoV HKU8
100

Miniopterus bat CoV1

Alpha-CoV

Human CoV NL63

Mus musculus MHV-1
Human CoV OC43

Human CoV OC43
TGEV

100

Pipistrellus bat CoV HKU5

Human CoV HKU1

Rhinolophus bat CoV HKU2

100

Tylonycteris bat CoV HKU4

100
62

Mink-CoV

0.50

91 Beta-CoV/Wuhan-Hu-1

99

Beta-CoV/Wuhan/IPBCAMS-WH-02
100

Bat SARSr-CoV BM48-31

100

Beta-CoV/Wuhan/IPBCAMS-WH-03

100

Bat SARSr-CoV WIV1

Beta-CoV

100 Bat SARSr-CoV WIV16

Rhinolophus bat CoV HKU2

100
91

Human CoV NL63

86

Human CoV 229E
98

0.50

PEDV
Scotophilus bat CoV 512

66

Miniopterus bat CoV HKU8
98

Miniopterus bat CoV1

Figure S1. Phylogenetic relationship of coronavirus based on ORF1a gene (A) and ORF1b gene (B) nucleotide sequences.

Alpha-CoV

Figure S1
S

90 Bat SARSr-CoV Rs4231
Bat SARSr-CoV WIV1

100 Bat SARSr-CoV WIV16

orf1b

87

Bat SARSr-CoV WIV1
95
100 Bat SARSr-CoV SHC014

98 Bat SARSr-CoV SHC014
SARS-CoV SZ3

Bat SARSr-CoV GX2013
97 Bat SARSr-CoV Rp3
100
Bat SARSr-CoV YNLF31C

100 SARS-CoV BJ01
100
Bat SARSr-CoV GX2013
100 Bat SARSr-CoV Rp3
100
Bat SARSr-CoV YNLF31C

94

Bat SARSr-CoV SX2013

Bat SARSr-CoV HuB2013

Bat SARSr-CoV Longquan-140
Bat SARSr-CoV BM48-31

97 Bat SARSr-CoV ZXC21
Bat SARSr-CoV ZC45

Beta-CoV

93

SARS-CoV-2
group

100 Bat SARSr-CoV Rf1
81
Bat SARSr-CoV SX2013

Bat SARSr-CoV Rf1
Bat SARSr-CoV HKU3-1

86

Pangolin-CoV

97

Bat CoV RaTG13

100
100
100

83

Beta-CoV/Wuhan/IPBCAMS-WH-01

99 85

Bat SARSr-CoV BM48-31

SARS-CoV-2
group

Pangolin-CoV
Bat CoV RaTG13
100

100

Beta-CoV/Wuhan/IPBCAMS-WH-02

Beta-CoV/Wuhan-Hu-1

100 Beta-CoV/Wuhan/IPBCAMS-WH-01
Beta-CoV/Wuhan/IPBCAMS-WH-02
100 Beta-CoV/Wuhan/IPBCAMS-WH-03

Beta-CoV/Wuhan/IPBCAMS-WH-03
Beta-CoV/Wuhan/IPBCAMS-WH-04
Beta-CoV/Wuhan/IPBCAMS-WH-05

72

Beta-CoV/Wuhan/IPBCAMS-WH-04
Beta-CoV/Wuhan/IPBCAMS-WH-05

86

Bat Hp-BetaCoV Zhejiang2013
Rousettus bat CoV HKU9

Rousettus bat CoV HKU9

Tylonycteris bat CoV HKU4

MERS-CoV
100

Tylonycteris bat CoV HKU4
Pipistrellus bat CoV HKU5

Pipistrellus bat CoV HKU5
95

MERS-CoV
Human CoV HKU1

Human CoV HKU1
100

Mus musculus MHV-1

100

Human CoV OC43

0.20

Human CoV NL63
Human CoV 229E
100

100

PEDV
Scotophilus bat CoV 512

88

Miniopterus bat CoV HKU8
100

Miniopterus bat CoV1

Alpha-CoV

Rhinolophus bat CoV HKU2
100

100

Human CoV OC43

Mink-CoV

Mink-CoV

83

Mus musculus MHV-1

TGEV

100

TGEV

100

Bat SARSr-CoV Longquan-140

Bat SARSr-CoV ZXC21
100 Bat SARSr-CoV ZC45

100

Beta-CoV/Wuhan-Hu-1

98

Bat SARSr-CoV HKU3-1

100

Bat Hp-BetaCoV Zhejiang2013

100

Bat SARSr-CoV SC2018

100

Bat SARSr-CoV HuB2013

100 100

100

100 SARS-CoV SZ3
100 SARS-CoV BJ01

Bat SARSr-CoV SC2018

90

Bat SARSr-CoV Rs4231

Beta-CoV

Bat SARSr-CoV WIV16

orf1a

100

0.20

PEDV

100

Scotophilus bat CoV 512
100

Miniopterus bat CoV HKU8

100

Miniopterus bat CoV1
Rhinolophus bat CoV HKU2

75
99

Figure S2. Phylogenetic relationship of coronavirus based on S gene (A) and M gene (B) nucleotide sequences.

Human CoV NL63
Human CoV 229E

Alpha-CoV

Figure S2

Contig_ID

Contig Length (nt)

Subject id

aa identity (%)

alignment length

q. start

q. end

s. start

s. end

e-value

bit score

Con_01

1306

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

86.8

423

37

1305

1

422

1.40E-221

767.3

Con_02

383

AVP78041|non-structural polyprotein 1ab [Bat SARS-like coronavirus]

96.1

127

3

383

431

557

7.50E-64

241.5

Con_03

398

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

70.6

102

2

307

867

968

6.50E-34

142.1

Con_04

541

AVP78030|non-structural polyprotein 1ab [Bat SARS-like coronavirus]

95.5

179

4

540

1311

1489

9.90E-94

341.3

Con_05

525

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

93.1

174

2

523

1495

1668

1.90E-94

343.6

Con_06

611

AVP78041|non-structural polyprotein 1ab [Bat SARS-like coronavirus]

92.7

165

60

554

1671

1835

6.30E-89

325.5

Con_07

307

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

96.2

53

2

160

1866

1918

1.90E-25

113.6

Con_08

721

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

95.5

179

167

703

2700

2878

9.10E-95

345.1

Con_09

1078

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

98.6

359

2

1078

2966

3324

1.80E-208

723.4

Con_10

987

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

99.7

329

1

987

3670

3998

8.20E-179

624.8

Con_11

751

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

100

202

144

749

3960

4161

3.00E-80

297

Con_12

2138

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

96.4

413

859

2094

4402

4814

5.10E-242

835.9

Con_13

562

AIA62319|ORF1ab polyprotein [BtRs-BetaCoV/GX2013]

100

186

3

560

5165

5350

5.80E-113

405.2

Con_14

512

ARI44798|orf1ab polyprotein [Bat coronavirus]

100

170

2

511

5307

5476

3.50E-101

365.9

Con_15

296

ATO98191|non-structural polyprotein 1ab [Bat SARS-like coronavirus]

100

46

157

294

5307

5352

6.50E-23

105.1

Con_16

983

ARI44798|orf1ab polyprotein [Bat coronavirus]

100

288

3

866

5431

5718

3.50E-166

582.8

Con_17

646

ATO98167|non-structural polyprotein 1ab [Bat SARS-like coronavirus]

98.1

215

2

646

5708

5922

2.10E-122

436.8

Con_18

640

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

98.6

213

2

640

5985

6197

9.50E-128

454.5

Con_19

832

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

92.2

244

1

723

6151

6394

2.20E-140

496.9

Con_20

1830

QHO60603|orf1ab polyprotein [Wuhan seafood market pneumonia virus]

98.6

570

2

1711

6527

7096

0.00E+00

1145.2

Con_21

496

QHO60594|surface glycoprotein [Wuhan seafood market pneumonia virus]

95.8

118

143

496

307

424

1.70E-63

240.7

Con_22

440

QHO60594|surface glycoprotein [Wuhan seafood market pneumonia virus]

96.6

145

1

435

378

522

9.80E-84

307.8

Con_23

381

QHO60594|surface glycoprotein [Wuhan seafood market pneumonia virus]

93.1

131

1

381

658

788

1.20E-61

234.2

Con_24

503

QHO60594|surface glycoprotein [Wuhan seafood market pneumonia virus]

100

157

3

473

785

941

7.00E-86

315.1

Con_25

646

ABD75323|spike protein [Bat SARS CoV Rf1/2004]

95.1

183

96

644

946

1128

3.20E-99

359.8

Con_26

381

QHO60595|orf3a protein [Wuhan seafood market pneumonia virus]

96.9

127

1

381

114

240

4.40E-72

268.9

Con_27

900

AVP78045|membrane protein [Bat SARS-like coronavirus]

99.5

222

170

835

1

222

2.40E-121

433.7

Con_28

359

QHO60599|orf7a protein [Wuhan seafood market pneumonia virus]

100

42

131

256

1

42

3.40E-18

89.7

Con_29

989

AVP78048|hypothetical protein [Bat SARS-like coronavirus]

95

121

461

823

1

121

1.40E-66

251.9

Con_30

488

QHO60601|nucleocapsid phosphoprotein [Wuhan seafood market pneumonia virus]

96.9

162

1

486

3

164

3.20E-91

332.8

Con_31

287

AAU04658|nucleocapsid protein [SARS coronavirus civet010]

97.8

46

2

139

258

303

7.70E-21

98.2

Con_32

555

QHO60601|nucleocapsid phosphoprotein [Wuhan seafood market pneumonia virus]

97.8

184

2

553

119

302

7.80E-78

288.5

Con_33

461

QHO60601|nucleocapsid phosphoprotein [Wuhan seafood market pneumonia virus]

98.2

109

2

328

257

365

1.50E-58

224.2

Con_34

375

QHO60602|orf10 protein [Wuhan seafood market pneumonia virus]

97.4

38

90

203

1

38

4.90E-15

79.3

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

Table S1. Contigs taxonomically annotated by using BLASTx against 2845 Coronavirus reference genomes.

bioRxiv preprint doi: https://doi.org/10.1101/2020.02.19.950253; this version posted February 20, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

Table S2. Comparing nt and aa sequence identity difference of ten genes among PangolinCov, 2019-nCoV, and BatCov-RaTG13
Genes
orf1ab
orf1a
orf1b
S
3a
E
M
orf6
orf7a
orf8
N
orf10
Nucleotide
orf1ab
orf1a
orf1b
S
3a
E
M
orf6
orf7a
orf8
N
orf10
Average
Amino Acid
orf1ab
orf1a
orf1b
S
3a
E
M
orf6
orf7a
orf8
N
orf10
Average

2019-nCoV (nt)
21290
13128
8072
3822
828
228
669
186
366
366
1260
117
2019-nCoV vs Pangolin-CoV
90.3%
89.9%
90.7%
88.3%
94.5%
98.3%
93.0%
95.1%
92.0%
91.7%
94.9%
99.1%
93.2%
2019-nCoV vs Pangolin-CoV
87.1%
96.8%
73.4%
97.5%
96.8%
97.4%
98.6%
96.3%
96.9%
94.8%
96.4%
97.3%
94.1%

RaTG13 (nt)
21287
13215
8072
3810
828
228
666
186
366
366
1260
117
2019-nCoV vs RaTG13
96.6%
96.2%
97.0%
91.5%
98.6%
100.0%
95.8%
98.8%
95.1%
96.9%
96.7%
99.1%
96.9%
2019-nCoV vs RaTG13
95.8%
98.6%
92.2%
96.7%
100.0%
100.0%
100.0%
100.0%
96.9%
94.8%
99.0%
97.3%
97.6%

Pangolin-CoV (nt)
13669 (partial)
7342 (partial)
6327 (partial)
2156 (partial)
379 (partial)
120 (partial)
669 (Complete)
175 (partial)
296 (partial)
366 (Complete)
1192 (partial)
117 (Complete)
Pangolin-CoV vs RaTG13
90.3%
90.3%
90.4%
87.3%
95.0%
98.3%
93.0%
93.8%
90.4%
91.5%
95.4%
98.3%
92.8%
Pangolin-CoV vs RaTG13
86.9%
97.0%
72.8%
95.4%
96.8%
97.4%
98.6%
96.3%
93.6%
96.6%
96.4%
94.6%
93.5%

